Company Filing History:
Years Active: 2008
Title: The Innovations of Albert Mekking
Introduction
Albert Mekking is a notable inventor based in Woerden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly with his work on erythropoietin formulations. His innovative approach has led to the development of a stable pharmaceutical formulation that is crucial for medical applications.
Latest Patents
Mekking holds a patent for an erythropoietin solution formulation. This formulation is distinguished by its use of tris-(hydroxymethyl)-aminomethane as a stabilizer, and it notably does not contain amino acids or human serum albumin. This innovation is essential for enhancing the stability and efficacy of erythropoietin in therapeutic settings.
Career Highlights
Albert Mekking is associated with Bioggnerix AG, a company that focuses on advancing pharmaceutical technologies. His work at Bioggnerix AG has positioned him as a key player in the development of innovative drug formulations. His expertise and dedication to research have contributed to the company's mission of improving healthcare solutions.
Collaborations
Mekking has collaborated with talented professionals in his field, including Stefan Arnold and Okke Franssen. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of pharmaceutical innovations.
Conclusion
Albert Mekking's contributions to the field of pharmaceuticals, particularly through his patent on erythropoietin formulations, highlight his role as an influential inventor. His work continues to impact the medical community positively, paving the way for future innovations in drug formulation.